IPO Guru

IPO Listed — 29 Apr 2026

Listing Price: ₹104.50 (+4.5% vs ₹100.00)

View GMP History →
Citius Transnet Investment Trust InvIT

Citius Transnet Investment Trust InvIT IPO Review

Citius Transnet Investment Trust InvIT IPO has been reviewed by 2 analysts, and the overall consensus is Strong Apply — carrying a score of 100. Out of the 2 analysts who have covered this IPO, 2 recommend subscribing — reflecting a mixed view from the analyst community.

The issue is priced in the band of ₹99-100 per share . Subscription ran from 17 Apr 2026 to 21 Apr 2026. As of now, the grey market premium (GMP) for Citius Transnet Investment Trust InvIT IPO is quoting at ₹3.6 (4%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.

General Review

Citius Transnet Investment Trust is an infrastructure investment trust holding road assets in India, sponsored through the EAAA India Alternatives platform. Its portfolio mixes toll and annuity assets contributing 82.3 percent and 17.7 percent of cash revenues. Both analysts who covered the trust said subscribe, though coverage was limited to two notes.

Listing Gains

An InvIT is bought for distribution yield rather than listing gains, and the notes frame it that way. Revenue was ₹2,165.62 crore in FY25, with asset size having scaled more than nine times between FY21 and FY25. With only two notes, both positive, there was little basis for a strong listing view.

Short Term Strategy

The notes describe a de-risked revenue profile, where annuity and hybrid annuity assets provide predictable fixed cash flows while toll assets vary with traffic. That mix is what supports near-term distributions. Toll revenue also benefits from inflation-linked rate revisions, giving some protection against rising costs.

Long Term Strategy

The long-term case rests on the acquisition pipeline. The notes identify eleven ROFO assets under NHAI concessions totalling about 2,366.8 lane-kilometres across six states, five already operational. If all were acquired, the portfolio could scale to roughly 5,773.5 lane-kilometres across 21 assets, materially improving diversification and scale.

Disclaimer: This review is an AI summary derived from the reviews of all analysts.

Analyst Sentiment

Analytical Score

How it's calculated?
Strong Apply
100 / 100

Recommend Subscribe

Based on 2 analyst reviews

2 / 2

Higher consensus indicates broader analyst agreement.

Analyst Review

Analyst Verdict View
Apply
Apply

Latest IPO Reviews

Frequently Asked Questions

Should I apply for Citius Transnet Investment Trust InvIT IPO?

Based on analyst coverage tracked on this page, the overall verdict for Citius Transnet Investment Trust InvIT IPO is Strong Apply. Out of 2 analysts who have reviewed this IPO, 2 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.

What does the score of 100 mean for Citius Transnet Investment Trust InvIT IPO?

The score of 100 is an aggregate of all analyst ratings tracked for Citius Transnet Investment Trust InvIT IPO. A score in this range indicates strong analyst confidence — most analysts are recommending a subscribe. Scroll down to read individual analyst verdicts for more context.

What was the actual listing price of Citius Transnet Investment Trust InvIT IPO?

Citius Transnet Investment Trust InvIT IPO listed on April 29, 2026 at ₹104.50 , against the issue price of ₹100.00 — a gain of +4.5% (₹4.5 per share). View the full GMP history page for day-wise pre-listing trends.

What is the price band and lot size of Citius Transnet Investment Trust InvIT IPO?

Citius Transnet Investment Trust InvIT IPO was priced at ₹99-100 per share. Subscription ran from 17 Apr 2026 to 21 Apr 2026.

Explore Citius Transnet Investment Trust InvIT IPO Further

Track every stage of this IPO:

Advertisement
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.